Biocompatibles

Accessibility links

Literature

Category
Date	to

Role of slow-release doxorubicin eluting beads (DEB) transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC).
Date	13 - 17 September 2008, Copenhagen, Denmark
Where presented	Cardiovascular and Interventional Radiology Society of Europe (CIRSE)
Author(s)	A Vit, M Sponza, G Piccoli et al
Resources	Download file

Treatment of hepatocellular carcinoma with drug eluting beads versus microspheres before transplant: imaging and histology results
Date	13 - 17 September 2008, Copenhagen, Denmark
Where presented	Cardiovascular and Interventional Radiology Society of Europe (CIRSE)
Author(s)	A Nicolini, L Martinetti, S Crespi
Resources	Download file

Long term results of doxorubicin loaded DC Bead in the treatment of HCC survival, recurrence free interval and quality of life
Date	13 - 17 September 2008, Copenhagen, Denmark
Where presented	Cardiovascular and Interventional Radiology Society of Europe (CIRSE)
Author(s)	A Vit, M Sponza, G Piccoli et al
Resources	Download file

Evidence for drug eluting beads.
Date	13 - 17 September 2008, Copenhagen, Denmark
Where presented	Cardiovascular and Interventional Radiology Society of Europe (CIRSE)
Author(s)	J Lammer, J Pelage, M Wassef et al
Resources	Download file

Drug-Eluting Beads: A Novel Neoadjuvant Treatment in Colorectal Metastases and Primary Liver Cancer
Date	12 September 2008
Where presented	ESSO 2008, The Hague, The Netherlands
Author(s)	Dr Julien Namur; Department of Neuroradiology, Hopital Lariboisiere, Paris, France
Resources	Download file

Preliminary results from an open registry evaluating Drug-Eluting Beads in primary and metastatic liver tumours
Date	12 September 2008
Where presented	ESSO 2008, The Hague, The Netherlands
Author(s)	Dr Robert Martin; Associate Professor of Surgery, Division of Surgical Oncology, University of Louisville, Kentucky, USA
Resources	Download file

Transarterial Chemoembolisation with Epirubicin Drug Eluting Bead versus Transarterial Embolisation before LIver Transplantation for Hepatocellular Carcinoma
Date	5 - 7 September 2008
Where presented	International Liver Cander Association (ILCA), 2008
Author(s)	A Nicolini, L Martinetti, S Crespi et al
Resources	Download file

Doxorubicin-loaded LC Bead chemoembolization for HCC (PRECISION TACE): Assessment of tumor necrosis with imaging and histologic follow-up
Date	5 - 7 September 2008
Where presented	International Liver Cander Association (ILCA), 2008
Author(s)	S Citron, M Dupuis, E Gallardo et al
Resources	Download file

Chemoembolization with doxorubicin-eluting beads for HCC in surgical and non-surgical candidates, with histological evidence of efficiency in transplanted patients
Date	5 September 2008, 11.15-12.30, The Fairmont Chicago Hotel
Where presented	International Liver Cancer Association (ILCA), Chicago, Illinois, USA
Author(s)	Dr Marty Sellers; Director, Liver Cancer Services Piedmont Hospital, Atlanta, USA
Resources	Download file

International hepatic arterial embolization registry for hepatocellular cancer: surgical downstaging and safety
Date	5 September 2008, 11.15-12.30, The Fairmont Chicago Hotel
Where presented	International Liver Cancer Association (ILCA), Chicago, Illinois, USA
Author(s)	Dr Robert Martin; Associate Professor of Surgery, Division of Surgical Oncology. University of Louisville, Kentucky, USA
Resources	Download file

Evaluation of Drug Loadable Porous Microspheres for Doxorubicin
Date	22 - 25 June 2008, Los Angeles, California
Where presented	WCIO 2008 & Best of ASCO
Author(s)	K Lee, E Liapi, M Buijs et al
Resources	Download file

Precision TACE: Improved Possibilities in Fighting Liver Cancer
Date	22 - 25 June 2008, Los Angeles, California
Where presented	WCIO 2008 & Best of ASCO
Author(s)	A Slanic, J Matela
Resources	Download file

Acutely Ruptured Hepatocellular Carcinoma: Should Transarterial Chemoembolization with Doxorubicin Drug-Eluting Microspheres Be the Initial Treatment of Choice?
Date	22 - 25 June 2008, Los Angeles, California
Where presented	WCIO 2008 & Best of ASCO
Author(s)	T H Nguyen, D Liu, D Imagawa
Resources	Download file

Biology and Advances in Drug-Eluting Beads
Date	22 - 25 June 2008
Where presented	WCIO & Best of ASCO 2008
Author(s)	Dr Peter Stratford
Resources	Download file

Product Assessment and Expanded Opportunities in Embolotherapy
Date	7 June 2008, Barcelona, Spain
Where presented	GEST 2008 Satellite Symposium
Author(s)	Dr Thierry De Baere, Institut de Cancerologie Gustave Roussy, Villejuif, France
Resources	Download file

Transarterial chemoembolization (TACE) with doxorubicin eluting beads (DEB) for the treatment of hepatocellular carcinoma (HCC)
Date	30 May - 3 June 2008, Chicago, USA
Where presented	American Society of Clinical Oncology (ASCO)
Author(s)	A. Vit, F. De Pauli, M. Sponza, et al
Resources	Download file

Interim Analysis of DC/LC Bead Open Surgical Registry in Primary and Metastatic Liver Tumours
Date	10 April 2008, Florence, Italy
Where presented	ET/ECIO Satellite Symposium
Author(s)	Dr Robert MARTIN, University of Kentucky, Lexington, USA
Resources	Download file

TACE with DC Bead as a pre-transplant treatment for HCC: results with anatomopathological data
Where presented	ET/ECIO Satellite Symposium
Author(s)	Professor Pierre GOFFETTE, Cliniques Universitaires de St Luc, Brussels, Belgium
Resources	Download file

TACE with DC Bead as a pre-transplant treatment for HCC: results with anatomopathological data
Date	10 April 2008
Where presented	ET/ECIO Satellite Symposium
Author(s)	Professor Pierre GOFFETTE, Cliniques Universitaires de St Luc, Brussels, Belgium
Resources	Download file

DC Bead for the Pathological Downstage of HCC to Transplant: A Case History
Date	April 2008, Barcelona, Spain
Where presented	ET/ECIO 2008
Resources	Download file

Page 5 of 7 pages < 1 2 3 4 5 6 7 >

DC Bead

Register for product updates

Product availability map

Regulatory notices and product safety data

Worldwide (excluding USA and Canada)

DC Bead^® is CE marked and is indicated for the treatment of malignant hypervascular tumours and loading with doxorubicin drug. DC Bead^® is also indicated for loading with irinotecan for the treatment of metastatic colorectal cancer (mCRC). For full prescribing information please refer to DC Bead instructions for use.

USA

DC Bead is not currently available for sale or distribution in the USA. DC Bead has not been submitted for approval to the FDA.

Canada

DC Bead^® with doxorubicin is indicated for trans-arterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC). DC Bead are also intended to be loaded with irinotecan for the purpose of embolization of vessels supplying malignant colorectal cancer metastasised to the liver (mCRC), and delivery of a local, controlled, sustained dose of irinotecan to the mCRC. For full prescribing information please refer to DC Bead Canada Instructions for Use

Tawain

DC Bead is approved by the Department of Health and is intended to be loaded with Mayne (Hospira) doxorubicin HCI for the purpose of embolisation of vessels supplying malignant hypervascularised tumour(s), and delivery of a local, controlled, sustained dose of doxorubicin. DC Bead is also indicated for the embolisation of nidus vessels without medication. Approved size ranges in Taiwan are 300-500µm and 500-700µm.